PlainRecalls
FDA Devices Critical Class I Terminated

Arrow-Trerotola PTD Set (Percutaneous Thrombolytic Device), REF PT-65509 (finished good kit) The Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) Catheter, in conjunction with the Arrow Rotator Drive Unit, permits mechanical declotting of native arterio-venous (AV) fistulae and synthetic dialysis grafts.

Reported: February 23, 2022 Initiated: January 11, 2022 #Z-0629-2022

Product Description

Arrow-Trerotola PTD Set (Percutaneous Thrombolytic Device), REF PT-65509 (finished good kit) The Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) Catheter, in conjunction with the Arrow Rotator Drive Unit, permits mechanical declotting of native arterio-venous (AV) fistulae and synthetic dialysis grafts.

Reason for Recall

The firm received reports indicating PTD tip separation during use.

Details

Recalling Firm
TELEFLEX MEDICAL INC
Units Affected
14583 units
Distribution
Worldwide distribution: US Nationwide and the countries of AU, BE, CA, CL, CZ, DE, ES, FR, GB, IL, IT, KR, KW, NL, PA, PH, PT, SA, TR.
Location
Morrisville, NC

Frequently Asked Questions

What product was recalled?
Arrow-Trerotola PTD Set (Percutaneous Thrombolytic Device), REF PT-65509 (finished good kit) The Arrow-Trerotola Percutaneous Thrombolytic Device (PTD) Catheter, in conjunction with the Arrow Rotator Drive Unit, permits mechanical declotting of native arterio-venous (AV) fistulae and synthetic dialysis grafts.. Recalled by TELEFLEX MEDICAL INC. Units affected: 14583 units.
Why was this product recalled?
The firm received reports indicating PTD tip separation during use.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 23, 2022. Severity: Critical. Recall number: Z-0629-2022.